TIANJIN PHARM DA REN TANG GRP
(SGX: T14)

TIANJIN ZHONGXIN PHARMACEUTICAL GROUP CORPORATION LIMITED is a China-based company mainly engaged in the development, manufacture and distribution of pharmaceutical products. The Company’s main products include Chinese patent medicines, western medicines, Chinese medicinal materials, pharmaceutical raw materials and preparations, biological medicines, dietary supplements and other products. The Company’s main products consist of drugs for treatment of cardiovascular diseases and enterogastritis, respiratory drugs, as well as antineoplastic drugs, among others. It distributes its products within domestic market and to overseas markets.

2.390 -

-0.040 (-1.65%)
Range 2.390 - 2.450   (2.51%)
Open 2.450
Previous Close 2.430
Bid Price 2.390
Bid Volume ('000) 8.6
Ask Price 2.400
Ask Volume ('000) 17.1
Volume ('000) 25
Value 60,201
Remark -
Delayed prices. Updated at 30 Oct 2024 17:10.
Data powered by

Upcoming Events

EGM

Meeting Date 22 November 2024
Meeting Time 2:00 PM
2.00 P.M. AT AN EGM OF THE COMPANY WILL BE HELD AT THE MEETING ROOM OF DA REN TANG MANSION, TIANJIN, THE PRC 300193 (CONCURRENTLY, A VIDEO CONFERENCING AT RNN CONFERENCE CENTRE, 137 CECIL STREET #04-01 CECIL BUILDING, SINGAPORE 069537 FOR HOLDERS OF THE S-SHARES IN SINGAPORE) ON FRIDAY, 22 NOVEMBER 2024 AT 2:00 P.M..

EGM

Meeting Date 22 November 2024
Meeting Time 2:00 PM
2.00 P.M. AT DA REN TANG MANSION, TIANJIN, THE PRC 300193 (CONCURRENTLY, A VIDEO CONFERENCING AT RNN CONFERENCE CENTRE, 137 CECIL STREET #04-01 CECIL BUILDING, SINGAPORE 069537 FOR HOLDERS OF THE S-SHARES IN SINGAPORE)

EGM

Meeting Date 22 November 2024
Meeting Time 2:00 PM
2.00 P.M. AT THE MEETING ROOM OF DA REN TANG MANSION, TIANJIN, THE PRC 300193 (CONCURRENTLY, A VIDEO CONFERENCING AT RNN CONFERENCE CENTRE, 137 CECIL STREET #04-01 CECIL BUILDING, SINGAPORE 069537 FOR HOLDERS OF THE S-SHARES IN SINGAPORE)
Data powered by SGX.
View All Events

About TJ DaRenTang USD

TIANJIN ZHONGXIN PHARMACEUTICAL GROUP CORPORATION LIMITED is a China-based company mainly engaged in the development, manufacture and distribution of pharmaceutical products. The Company’s main products include Chinese patent medicines, western medicines, Chinese medicinal materials, pharmaceutical raw materials and preparations, biological medicines, dietary supplements and other products. The Company’s main products consist of drugs for treatment of cardiovascular diseases and enterogastritis, respiratory drugs, as well as antineoplastic drugs, among others. It distributes its products within domestic market and to overseas markets.

Loading Chart...

Please login to view stock data and analysis